Multicenter Outcome Registry of AnaLgesic Effect of SCS(MORALES) Registry Protocol
Launched by CARDIO SURGICAL PARTNERS · Sep 9, 2020
Trial Information
Current as of May 07, 2025
Recruiting
Keywords
ClinConnect Summary
The MORALES Registry is a clinical trial designed to gather important information about spinal cord stimulation (SCS) devices, which are used to relieve pain. The goal is to help doctors choose the most effective type of SCS device for their patients based on the causes and locations of their pain. This study is currently recruiting participants of all ages, and anyone with approved medical conditions for SCS implants can be considered for eligibility.
If you join this trial, you will be part of a group that helps researchers understand which SCS devices work best for different types of pain. Participants will have the opportunity to share their experiences with the treatment, which may help improve pain management for others in the future. It's important to know that this study does not exclude anyone based on gender, and it focuses on those who have been approved for SCS implants by the FDA and government payors. Your involvement could make a significant difference in advancing pain relief treatments!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • FDA approved indications for SCS implants, for commercial and government(medicare, medi-cal etc) approved payors
- Exclusion Criteria:
- • -
About Cardio Surgical Partners
Cardio Surgical Partners is a leading organization dedicated to advancing cardiovascular care through innovative surgical solutions and comprehensive clinical research. With a focus on improving patient outcomes and enhancing surgical techniques, the organization collaborates with top-tier medical institutions and experts in the field. By sponsoring clinical trials, Cardio Surgical Partners aims to evaluate and implement cutting-edge therapies that address critical challenges in cardiac surgery, thus contributing to the evolution of best practices and enhanced patient care in the cardiovascular domain.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reno, Nevada, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials